Immunotherapy found safe for type 1 diabetes in landmark trial – Medical News Today
Medical News Today |
Immunotherapy found safe for type 1 diabetes in landmark trial
Medical News Today A new trial investigates the safety profile of proinsulin peptide immunotherapy for treating type 1 diabetes, and the results are encouraging. Immunotherapy shows promise in treatment of Type 1 diabetes Immunotherapy Promising for Diabetes: Study | The Scientist … Immunotherapy for type I diabetes safe and well-tolerated, report … |
